Herbs (Global Traditional) · Native American
Yellow Dock (Rumex crispus) (Rumex crispus)
Moderate Evidencebotanical1 PubMed Study
Hermetica Superfood Encyclopedia
Yellow dock (Rumex crispus) contains anthraquinone compounds that provide mild laxative effects and demonstrate antimicrobial properties in laboratory studies. The plant's iron content and phenolic compounds may support digestive health through enhanced bile production and bowel regularity.
Yellow dock (Rumex crispus) is a perennial herb native to Europe, now naturalized worldwide, belonging to the Polygonaceae family with roots used medicinally. The root is typically harvested, dried, and extracted via fluid extracts, tinctures, or decoctions, containing 0.1-4% anthraquinones as key bioactive compounds.
No human clinical trials, RCTs, or meta-analyses have been conducted on yellow dock according to available research. All evidence comes from in vitro and animal studies, including one study showing anti-acetylcholinesterase activity (IC50 31.6 μg/mL) and cytotoxicity against cancer cell lines, but without human data or PMIDs for clinical trials.
No clinically studied dosage ranges are available as human trials are absent. Traditional forms include root fluid extract at 1:1 (25% concentration), powders, or decoctions without standardization specifics. Consult a healthcare provider before starting any new supplement.
Yellow Dock (Rumex crispus) root and leaves contain a range of nutritionally and pharmacologically relevant compounds. Primary bioactive constituents include anthraquinone glycosides (approximately 2-4% in dried root), predominantly emodin, chrysophanol, and physcion, which are responsible for laxative effects. Tannins are present at roughly 8-12% in the root (predominantly gallotannins and catechins), contributing astringent properties. Oxalic acid is notably high in leaves (approximately 300-500 mg per 100g fresh weight), which significantly reduces mineral bioavailability through formation of insoluble calcium and iron oxalates — a critical bioavailability caveat. Iron content in leaves is approximately 2-3 mg per 100g fresh weight, though absorption is substantially inhibited by oxalate binding. Vitamin C is present at approximately 13-14 mg per 100g in fresh leaves. Rumicin (lapaol) is a unique naphthalene derivative found in the root. Flavonoids including quercetin and its glycosides are present at approximately 0.5-1.5% dry weight. Roots contain beta-sitosterol and other phytosterols at trace levels. Protein content in dried root is approximately 6-8% dry weight. Crude fiber content is approximately 15-20% in dried root. Calcium is present at roughly 60-70 mg per 100g fresh leaf but is largely bound and poorly absorbed due to oxalate complexation. Potassium is approximately 390-400 mg per 100g fresh leaves with relatively good bioavailability. Magnesium is present at approximately 25-30 mg per 100g. Limited human pharmacokinetic data exists for anthraquinone absorption; animal studies suggest partial hepatic metabolism with enterohepatic recirculation of active metabolites.
Yellow dock's anthraquinone compounds, primarily chrysophanol and emodin, stimulate colonic motility by irritating the intestinal mucosa and increasing water secretion into the bowel. The plant's tannins and phenolic acids exhibit antimicrobial activity by disrupting bacterial cell membranes and inhibiting enzyme systems. Iron content may support hemoglobin synthesis, while flavonoids provide antioxidant effects through free radical scavenging.
No human clinical trials have been conducted specifically on yellow dock supplementation. Laboratory studies demonstrate antimicrobial activity against various bacterial strains with minimum inhibitory concentrations ranging from 50-200 μg/mL. In vitro antioxidant studies show moderate DPPH radical scavenging activity at concentrations of 100-500 μg/mL. Traditional use data suggests laxative effects occur within 6-12 hours of consumption, but controlled studies are lacking.
Yellow dock may cause abdominal cramping, diarrhea, and electrolyte imbalances due to its anthraquinone content. The high oxalate content can interfere with calcium absorption and may contribute to kidney stone formation in susceptible individuals. Pregnancy and breastfeeding safety is unknown, and the herb should be avoided during these periods. May interact with anticoagulant medications due to potential effects on vitamin K absorption.
